Should Stroke Subtype Influence Anticoagulation Decisions to Prevent Recurrence in Stroke Patients with Atrial Fibrillation?
Stroke 32:2828-2832, Evans,A.,et al, 2001
Combination Therapy With Clopidogrel and Aspirin
Stroke 32:2948-2949, Albers,G.W. &Amerenco,P., 2001
Acute Stroke Care in Non-urban Emergency Departments
Neurol 57:2006-2012, Burgin,W.S.,et al, 2001
Treatment of Acute Basilar Artery Thrombosis With a Combination of Systemic Alteplase and Tirofiban, a Nonpeptide Platelet Glycoprotein IIb/IIIa Inhibitor: Report of Four Cases
Radiology 221:795-801, Junghans,U.,et al, 2001
Randomized Controlled Trial of Zonisamide for the Treatment of Refractory Partial-onset Seizures
Neurol 57:1774-1779, Faught,E.,et al, 2001
Management of Epilepsy in Adolescents and Adults
Lancet 356:323-329, Brodie,M.J. & French,J.A., 2000
Thienopyridines or Aspirin to Prevent Stroke and Other Serious Vascular Events in patients at High Risk of Vascular Disease?
Stroke 31:1779-1784, Hankey,G.J. et al, 2000
Visual Impairment in Children with Epilepsy Treated with Vigabatrin
Ann Neurol 48:60-64, Gross-Tsur,V. et al, 2000
Symptomatic Intracranial Atherosclerosis
Neurol 55:490-497, 465, Thijs,V.N. & Albers,G.W., 2000
Management of Intracranial Bleeding Associated with Anticoagulation: Balancing the Risk of Further Bleeding Against Thromboembolism From Prosthetic Heart Valves
JNNP 69:396-398, Crawley,F. et al, 2000
Treatment of Acute Ischemic Stroke
NEJM 343:710-722, Brott, T. & Bogousslavsky, J., 2000
Intracranial Percutaneous Transluminal Angioplasty for Arteriosclerotic Stenosis
Arch Neurol 57:1625-1630, Alazzaz,A.,et al, 2000
Primary Stenting for High-Grade Basilar Artery Stenosis
AJNR 21:1744-1749, Phatouros,C.C.,et al, 2000
Cost-Effectiveness of New Antiplatelet Regimens Used as Secondary Prevention of Stroke or Transient Ischemic Attack
Arch Int Med 160:2773-2778, Sarasin,F.P.,et al, 2000
Safety of Discontinuation of Anticoagulation in Patients with Intracranial Hemorrhage at High Thromboembolic Risk
Arch Neurol 57:1710-1713,1682, Phan,T.G.,et al, 2000
Diagnostic Testing for Coagulopathies in Patients With Ischemic Stroke
Stroke 31:3067-3078, Bushnell,C.D. & Goldstein,L.B., 2000
Sturge-Weber Syndrome
Neurol 55:1472-1479, Arzimanoglou,A.A.,et al, 2000
When Drugs Don't Work
Neurol 55:1780-1784, Benbadis,S.R.,et al, 2000
AGGRENOX: A Combination of Antiplatelet Drugs for Stroke Prevention
The Medical Letter 442:11-12, , 2000
Stroke in Patients with Heart Failure and Reduced Left Ventricular Ejection Fraction
Neurol 54:288-294, Pullicini,P.M.,et al, 2000
Driving in Adults with Refractory Localization-Related Epilepsy
Neurol 54:625-630, Berg,A.T.,et al, 2000
New Drugs:Which Should Be Included in the Formulary?, Epilepsy:All New Drugs Should Be Included
Arch Neurol 57:272-273,275, Pierre-Louis,S.J.C., 2000
Restrictions on the Availability of Antiepileptic Drugs
Arch Neurol 57:273-274,275, Bergen,D.C., 2000
Early Identification of Refracvtory Epilepsy
NEJM 342:314-319, Kwan,P.&Brodie,M.J., 2000
Aspirin for the Primary Prevention of Stroke and Other Major Vascular Events
ArchNeurol 57:326-332,306, Hart,R.G.,et al, 2000
Early Lacunar Strokes Complicating Polyarteritis Nodosa
Neurol 54:883-889, Reichhart,M.D.,et al, 2000
Vagus Nerve Stimulation Therapy for Epilepsy in Older Adults
Neurol 54:1179-1182, Sirven,J.I.,et al, 2000
Aspirin-Associated Intracerebral Hemorrhage
Neurol 54:2298-2301, Wong,K.S.,et al, 2000
Update on Antiplatelet Therapy for Stroke Prevention
Arch Int Med 160:1579-1582, Sacco,R.L.& Elkind,M.S., 2000
Thrombotic Thrombocytopenic Purpura Associated with Clopidogrel
NEJM 342:1773-1777,1824, Bennett,C.L.,et al, 2000
Intravenous Valproate in Pediatric Epilepsy Patients with Refractory Status Epilepticus
Neurol 54:2188-2189, Uberall,M.A.,et al, 2000
Reduced Prevalence of AD in Users of NSAIDs and H2 Receptor Antagonists
Neurol 54:2066-2071, Anthony,J.C.,et al, 2000
Indications for Early Aspirin Use in Acute Ischemic Stroke
Stroke 31:1240-1249, Chen,Z.,et al, 2000
Low Molecular-Weight Heparin Versus Aspirin in Patients With Acute Ischaemic Stroke and Atrial Fibrillation: A Double-Blind Randomised Study
Lancet 355:1205-1210, Berge,E.,et al, 2000
Oxcarbazepine: Double-blind, Randomized, Placebo-control, Monotherapy Trial for Partial Seizures
Neurol 52:732-737, Schachter,S.C. et al, 1999
Topiramate in Clinical Practice:First Year's Postlicensing Experience in a Specialist Epilepsy Clinic
JNNP 66:759-763, Kellett,M.W.,et al, 1999
A Metaregression Analysis of the Dose-Response Effect of Aspirin on Stroke
Arch Int Med 159:1248-1253, Johnson,E.S.,et al, 1999
Low-Dose and High-Dose Acetylsalicylic Acid for Patients Undergoing Carotid Endarterectomy:A Randomised Controlled Trial
Lancet 353:2179-2184,2172, Taylor,D.W.,et al, 1999
Seizure Control and Mortality in Epilepsy
Ann Neurol 46:45-50, Sperling,M.R.,et al, 1999
Safety and Efficacy of Vigabatrin and Carbamazepine in Newly Diagnosed epilepsy:A Multicentre Randomised Double-Blind Study
Lancet 354:13-19, Chadwick,D., 1999
Seizure Frequency and the Health-Related Quality of Life of Adults with epilepsy
Neurol 53:162-166, Leidy,N.K.,et al, 1999
Therapeutic Benefit, Aspirin Revisited in Light of the Introduction of Clopidogrel
Stroke 30:1716-1721, Gorelick,P.B.,et al, 1999
Phenobarbital Compared with Phenytoin for the Treatment of Neonatal Seizures
NEJM 341:485-489, Painter,M.J.,et al, 1999
Prospective Study of Aspirin Use and Risk of Stroke in Women
Stroke 30:1764-1771, Iso,H.,et al, 1999
Antiplatelet Treatment Does Not Reduce the Severity of Subsequent Stroke
Neurol 53:825-829, Sivenius,J.,et al, 1999
Patient-Oriented Outcome Assessment After Temporal Lobectomy for Refractory Epilepsy
Neurol 53:687-694, 662, Gilliam,F.,et al, 1999
Reassessment:Vagus Nerve Stimulation for Epilepsy
Neurol 53:666-669, Fisher,R.S.&Handforth,A., 1999
Dipyridamole Plus Aspirin in Cerebrovascular Disease
Arch Neurol 56:1087-1092, Wilterdink,J.L.&Easton,J.D., 1999
Treatment and Secondary Prevention of Stroke:Evidence, Costs, and Effects on Individuals and Populations
Lancet 354:1457-1463, Hankey,G.J.&Warlow,C.P., 1999
Primary Prevention of Arterial Thromboembolism in Non-Rheumatic Atrial Fibrillation in Primary Care:Randomised Controlled Trial Comparing Two Intensities of Coumarin with Aspirin
BMJ 319:958-964, Hellemons,B.S.P.,et al, 1999